Prestige Consumer Healthcare Inc. Reports Third Quarter and Year-to-Date Fiscal 2026 Results

Go back to Prestige Consumer Healthcare Inc. Reports Third Quarter and Year-to-Date Fiscal 2026 Results

Prestige Brands (PBH) Reports In-Line Q3 EPS, Beats on Revenue; Offers FY26 Guidance

February 5, 2026 6:10 AM EST

Prestige Brands (NYSE: PBH) reported Q3 EPS of $1.14, in-line with the analyst estimate of $1.14. Revenue for the quarter came in at $283.44 million versus the consensus estimate of $281.12 million.

GUIDANCE:

Prestige Brands sees FY2026 EPS of $4.54, versus the consensus of $4.56. Prestige... More